Abstract
Bladder cancer is a common disease, and causes significant morbidity and mortality. It is estimated that there will be 56,500 new cases diagnosed in the United States in 2002, and that 12,600 men and women will die of the disease (Jemal et al. 2002). The majority of tumors are transitional cell carcinomas that arise from the transitional epithelium of the bladder mucosa. Superficial transitional cell carcinomas account for about 75% of all cases, and have a low potential to metastasize. The remaining 25% of tumors invade the muscularis propria of the bladder wall, and frequently spread to the lymph nodes and distant sites, making muscle-invasive bladder cancer a life-threatening disease. Lymph node involvement at diagnosis is associated with a high risk of occult metastatic disease and has an ominous prognosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrews B, Shariat SF, Kim JH et al (2002) Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol 167: 1475–1481
Ballon SC, Berman ML, Lagasse LD et al (1981) Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol 57: 90–95
Bao-Shan J, Wallace S (1985) Lymphatic imaging of solid tumors. In: Clouse ME, Wallace S (eds) Lymphatic imaging. Lymphography, computed tomography and scintigraphy. Williams and Wilkins, Baltimore, pp 290–450
Barentsz JO, Witjes JA, Ruijs JH (1997) What is new in bladder cancer imaging. Urol Clin North Am 24: 583–602
Bassi P, Ferrante GD, Piazza N et al (1999) Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 161: 1494–1497
Blandy JP, Jenkins BJ, Fowler CG et al (1988) Radical radiotherapy and salvage cystectomy for T2/3 cancer of the bladder. Prog Clin Biol Res 260: 447–451
Bochner BH, Esrig D, Groshen S et al (1997) Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer. Clin Cancer Res 3: 1615–1622
Bochner BH, Herr HW, Reuter VE (2001) Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 166: 2295–2296
Boersma LJ, van den Brink M, Bruce AM et al (1998) Estimation of the incidence of late bladder and rectum complications after high-dose (70–78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41: 83–92
Bretheau D, Ponthieu A (1996) Results of radical cystectomy and pelvic lymphadenectomy for bladder cancer with pelvic node metastases. Urol Int 57: 27–31
Byrne RR, Shariat SF, Brown R et al (2001) E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow-up. J Urol 165: 1473–1479
Coppin C, Gospodarowicz M, James K et al (1996) The NCI-Canada trial of concurrent cisplatin and radiotherapy for muscle invasive bladder cancer. J Clin Oncol 14: 2901–2907
Duncan W, Quilty PM (1986) The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7: 299–310
Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys 21: 109–122
Fossa SD, Waehre H, Aass N et al (1993) Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72: 3036–3043
Frazier HA, Robertson JE, Dodge RK et al (1993) The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71: 3993–4001
Freiha F, Reese J, Torti FM (1996) A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155: 495–499
Gospodarowicz MK, Hawkins NV, Rawlings GA et al (1989) Radical radiotherapy for the muscle invasive transitional cell carcinoma of the bladder: Failure analysis. J Urol 142: 1448–1454
Gospodarowicz MK, Rider WD, Keen CW et al (1991) Bladder cancer: long term follow-up results of patients treated with radical radiation. Clin Oncol 3: 155–161
Greven KM, Solin LJ, Hanks GE (1990) Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 65: 908–912
Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19: 3745–3749
Gudemann CJ, Weitz J, Kienle P et al (2000) Detection of hematogenous micrometastasis in patients with transitional cell carcinoma. J Urol 164: 532–536
Heicappell R, Muller-Mattheis V, Reinhardt M et al (1999) Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[18F]-2deoxy-D-glucose. Eur Urol 36: 582–587
Herr HW, Donat SM (2001) Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 165: 62–64
Jahnson S, Pedersen J, Westman G (1991) Bladder carcinoma-a 20-year review of radical irradiation therapy. Radiother Oncol 22: 111–117
Jemal A, Thomas A, Murray T et al (2002) Cancer statistics, 2002. CA Cancer J Clin 52: 23–47
Jenkins BJ, Caulfield MJ, Fowler CG et al (1988) Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62: 342–346
Kava BR, Dalbagni G, Conlon KC et al (1998) Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer. Ann Surg Oncol 5: 173–180
Lanciano RM, Corn BW (1994) The role of surgical staging for cervical carcinoma. Semin Radiat Oncol 4: 46–51
Larsen LE, Engelholm SA (1994) The value of three-dimensional radiotherapy planning in advanced carcinoma of the urinary bladder based on computed tomography. Acta Oncol 33: 655–659
Lerner SP, Skinner DG (2000) Radical cystectomy for bladder cancer. In: Vogelzang NJ, Shipley WU, Scardino PT et al (eds) Comprehensive textbook of genitourinary oncology, 2nd edn. Lippincott Williams and Wilkins, Philadelphia, p 1177
Lerner SP, Skinner DG, Lieskovsky G et al (1993) The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 149: 758–764
Lianes P, Charytonowicz E, Cordon-Cardo C et al (1998) Bio-marker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network. Clin Cancer Res 4: 1267–1271
Logue JP, Sharrock CL, Cowan RA et al (1998) Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 41: 929–931
Malone S, Szanto J, Perry G et al (2000) A prospective comparison of three systems of patient immobilization for prostate radiotherapy. Int J Radiat Oncol Biol Phys 48: 657–665
Mangan CE, Rubin SC, Rabin DS et al (1986) Lymph node nomenclature in gynecologic oncology. Gynecol Oncol 23: 222–226
Marks LB (1990) A standard dose of radiation for “micro- scopic disease” is not appropriate. Cancer 66: 2498–2502
Martinez-Monge R, Fernandes PS, Gupta N et al (1999) Cross-sectional nodal atlas: a tool for the definition of clinical target volumes in three-dimensional radiation therapy planning. Radiology 211: 815–828
Miralbell R, Nouet P, Rouzaud M et al (1998) Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment. Int J Radiat Oncol Biol Phys 41: 741–746
Moonen L, van de Voet H, de Nijs R et al (1998) Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment. Radiother Oncol 49: 149–155
Narayan K, Hicks RJ, Jobling T et al (2001) A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer 11: 263–271
Nutting MN, Convery DJ, Cosgrove VP et al (2000) Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48: 649–656
Okunieff P, Morgan D, Niemierko A et al (1995) Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 32: 1227–1237
Overgaard M, Jensen MB, Overgaard J et al (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353: 1641–1648
Panici PB, Scambia G, Baiocchi G et al (1992) Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies. Obstet Gynecol 79: 498–502
Parkin J, Keeley FX, Timoney AG (2002) Laparoscopic lymph node sampling in locally advanced prostate cancer. BJU Int 89: 14–17
Pollack A, Zagars GK, Swanson DA (1994) Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys 30: 267–277
Portelance L, Chao KS, Grigsby PW et al (2001) Intensity-modulated radiation therapy ( IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving para-aortic irradiation. Int J Radiat Oncol Biol Phys 51: 1–266
Potish RA, Dusenbery KE (1990) Enteric morbidity of postoperative pelvic external beam and brachytherapy for uterine cancer. Int J Radiat Oncol Biol Phys 18: 1005–1010
Potish RA, Twiggs LB, Prem KA et al (1984) The impact of extraperitoneal surgical staging on morbidity and tumor recurrence following radiotherapy for cervical carcaioma. Am J Clin Oncol 7: 245–251
Poulsen AL, Horn T, Steven K (1998) Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160:2015–2019; discussion 2020
Poulsen J, Krarup T (1995) Pelvic lymphadenectomy (staging) in patients with bladder cancer: laparoscopic versus open approach. Scand J Urol Nephrol Suppl 172: 19–21
Rabbani F, Richon VM, Orlow I et al (1999) Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst 91: 874–881
Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337: 956–962
Reinhardt MJ, Ehritt-Braun C, Vogelgesang D et al (2001) Metastatic lymph nodes in patients with cervix cancer: detection with MR imaging and FDG PET. Radiology 21: 776–782
Roeske JC, Lujan A, Rotmensch J et al (2000) Intensity-modulated whole pelvic radiation in patients with gyncologic malignancies. Int J Radiat Oncol Biol Phys 48: 1613–1621
Rouviere H (1938) Anatomy of the human lymphatic system. Edwards, Ann Arbor
Roy C, Bras Y, Mangold L et al (1997) Small pelvic lymph node metastases: evaluation with MR imaging. Clin Radiol 52: 437–440
Shackley DC, Irving SO, Brough WA et al (1999) Staging laparoscopic pelvic lymphadenectomy in prostate cancer. BJU Int 83: 260–264
Sherif A, de la Torre M, Malmstrom PU et al (2001) Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol 166: 812–815
Skinner DG, Tift JP, Kaufman JJ (1982) High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer. J Urol 127: 671–674
Skinner DG, Daniels JR, Russell CA et al (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145:459–464; discussion 464–457
Smaaland R, Akslen L, Tonder B et al (1991) Radical radiation treatment of invasive and locally advanced bladder cancer in elderly patients. Br J Urol 67: 61–69
Smith JA, Whitmore WF (1981) Regional lymph node metastases from bladder cancer. J Urol 126: 591–593
Sobin LH, Wiitekind CH (1997) TNM classification of malignant tumors, Union Internationale Contre le Cancer, 5th edn. Wiley-Liss, New York
Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 3 666–675
Stockle M, Meyenburg W, Wellek S et al (1995) Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 153: 47–52
Studer UE, Bacchi M, Biedermann C et al (1994) Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol 152: 81–84
Swana HS, Grossman D, Anthony JN et al (1999) Tumor content of the anti-apoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341: 452–453
Tiguert R, Bianco FJ, Oskanian P et al (2001) Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma. J Urol 166: 2155–2160
Turner SL, Swindell SL, Bowl N et al (1997) Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys 39: 355–360
Turner WH, Markwalder R, Perrig S et al (1998) Meticulous pelvic lymphadenectomy in surgical treatment of the invasive bladder cancer: an option or a must? Eur Urol 33 [Suppl 41: 21–22
Vale JA, A’Hern RP, Liu K et al (1993) Predicting the outcome of radical radiotherapy for invasive bladder cancer. Eur Urol 24: 48–51
Vieweg J, Gschwend JE, Herr HW et al (1999) Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 161: 449–454
Williams AD, Cousins C, Soutter WP et al (2001) Detection of pelvic lymph node metastases in gynecologic malignancies: a comparison of CT, MR imaging, and positron emission tomography. Am J Roentgenol 177: 343–348
Williams PL (1995) Gray’s anatomy, 38th edn. Churchill Livingstone, New York
Wishnow KI, Johnson DE, Ro JY et al (1987) Incidence, extent and location of unsuspected pelvic lymph node metastases in patients undergoing radical cystectomy for bladder cancer. J Urol 137: 408–410
Withers HR, Peters LJ, Taylor JMG (1995) Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 31: 353–359
Zincke H, Patterson DE, Utz DC et al (1985) Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic lymph node disease. Br J Urol 57: 156–159
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Milosevic, M., Gospodarowicz, M., Jewett, M., Bristow, R., Haycocks, T. (2004). Intensity-Modulated Radiation Therapy for Lymph Node Metastases in Bladder Cancer. In: Grégoire, V., Scalliet, P., Ang, K.K. (eds) Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06270-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-06270-8_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07463-9
Online ISBN: 978-3-662-06270-8
eBook Packages: Springer Book Archive